APP and Alzheimer disease: This mouse model expresses mutant human amyloid precursor protein (APP) and presenilin protein 1 (PS1), causing AD‐like amyloid plaque formation as early as 4 months of age while cognitive impairment becomes observable around 6–8 months of age (Savonenko et al, 2005; Jackson et al, 2013).